MALAT1 and cancer: For instance, lncRNA PCA3 has emerged as a promising biomarker for early prostate cancer detection [16], and the aberrant expression of lncRNA MALAT1 in cancer cells underlines its potential as a therapeutic target in cancer treatment [17, 18].